Cargando…

Should we operate on all patients with COVID-19 and proximal femoral fractures? An analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in Northern Italy

PURPOSE: This study aims to evaluate 30–60–90-day mortality of operated proximal femur fractures (PFFs) suffering from COVID-19 and correlation with patients’ clinical presentation and comorbidities. METHODS: Between February 1, 2020, and December 31, 2020, patients with COVID-19 infection and surgi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusini, Federico, Massè, Alessandro, Risitano, Salvatore, Ferrera, Andrea, Enrietti, Emilio, Zoccola, Kristijan, Bianco, Giuseppe, Zanchini, Fabio, Colò, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366488/
https://www.ncbi.nlm.nih.gov/pubmed/34401931
http://dx.doi.org/10.1007/s00264-021-05166-3
_version_ 1783738895922364416
author Fusini, Federico
Massè, Alessandro
Risitano, Salvatore
Ferrera, Andrea
Enrietti, Emilio
Zoccola, Kristijan
Bianco, Giuseppe
Zanchini, Fabio
Colò, Gabriele
author_facet Fusini, Federico
Massè, Alessandro
Risitano, Salvatore
Ferrera, Andrea
Enrietti, Emilio
Zoccola, Kristijan
Bianco, Giuseppe
Zanchini, Fabio
Colò, Gabriele
author_sort Fusini, Federico
collection PubMed
description PURPOSE: This study aims to evaluate 30–60–90-day mortality of operated proximal femur fractures (PFFs) suffering from COVID-19 and correlation with patients’ clinical presentation and comorbidities. METHODS: Between February 1, 2020, and December 31, 2020, patients with COVID-19 infection and surgically treated PFF were included. Patients’ demographic characteristics, oxygen (O2) therapy, comorbidities, and AO type fracture were collected. Chi-square test or Fisher test and hazard ratio were used to assessing the correlation between mortality rate, patient characteristics, and COVID-19 status. Kaplan-Meyer curve was used to analyze 30–60–90-day mortality. Level of significance was set as p < 0.05. RESULTS: Fifty-six patients (mean age of 82.7 ± 8.85 years) were included. Thirty-day mortality rate was 5%, which increased to 21% at 60 days and 90 days. Eleven patients died, eight due to AO type A-like and three due to AO type B-like fractures. No significant difference in mortality rate between patients with cardiopulmonary comorbidity or no cardiopulmonary comorbidity was found (p = 0.67); a significant difference in patients with chronic obstructive pulmonary disease (COPD) or history of pulmonary embolism (PE) and patients without COPD was found (p = 0.0021). A significant difference between asymptomatic/mild symptomatic COVID-19 status and symptomatic COVID-19 status was found (p = 0.0415); a significant difference was found for O2 therapy with < 4 L/min and O2 therapy ≥ 4 L/min (p = 0.0049). CONCLUSION: Thirty-day mortality rate of COVID-19 infection and PFFs does not differ from mortality rate of non-COVID-19 PFFs. However, patients with pre-existing comorbidities and symptomatic COVID-19 infection requiring a high volume of O2 therapy have a higher incidence of 60–90-day mortality when surgically treated.
format Online
Article
Text
id pubmed-8366488
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83664882021-08-17 Should we operate on all patients with COVID-19 and proximal femoral fractures? An analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in Northern Italy Fusini, Federico Massè, Alessandro Risitano, Salvatore Ferrera, Andrea Enrietti, Emilio Zoccola, Kristijan Bianco, Giuseppe Zanchini, Fabio Colò, Gabriele Int Orthop Original Paper PURPOSE: This study aims to evaluate 30–60–90-day mortality of operated proximal femur fractures (PFFs) suffering from COVID-19 and correlation with patients’ clinical presentation and comorbidities. METHODS: Between February 1, 2020, and December 31, 2020, patients with COVID-19 infection and surgically treated PFF were included. Patients’ demographic characteristics, oxygen (O2) therapy, comorbidities, and AO type fracture were collected. Chi-square test or Fisher test and hazard ratio were used to assessing the correlation between mortality rate, patient characteristics, and COVID-19 status. Kaplan-Meyer curve was used to analyze 30–60–90-day mortality. Level of significance was set as p < 0.05. RESULTS: Fifty-six patients (mean age of 82.7 ± 8.85 years) were included. Thirty-day mortality rate was 5%, which increased to 21% at 60 days and 90 days. Eleven patients died, eight due to AO type A-like and three due to AO type B-like fractures. No significant difference in mortality rate between patients with cardiopulmonary comorbidity or no cardiopulmonary comorbidity was found (p = 0.67); a significant difference in patients with chronic obstructive pulmonary disease (COPD) or history of pulmonary embolism (PE) and patients without COPD was found (p = 0.0021). A significant difference between asymptomatic/mild symptomatic COVID-19 status and symptomatic COVID-19 status was found (p = 0.0415); a significant difference was found for O2 therapy with < 4 L/min and O2 therapy ≥ 4 L/min (p = 0.0049). CONCLUSION: Thirty-day mortality rate of COVID-19 infection and PFFs does not differ from mortality rate of non-COVID-19 PFFs. However, patients with pre-existing comorbidities and symptomatic COVID-19 infection requiring a high volume of O2 therapy have a higher incidence of 60–90-day mortality when surgically treated. Springer Berlin Heidelberg 2021-08-16 2021-10 /pmc/articles/PMC8366488/ /pubmed/34401931 http://dx.doi.org/10.1007/s00264-021-05166-3 Text en © SICOT aisbl 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Fusini, Federico
Massè, Alessandro
Risitano, Salvatore
Ferrera, Andrea
Enrietti, Emilio
Zoccola, Kristijan
Bianco, Giuseppe
Zanchini, Fabio
Colò, Gabriele
Should we operate on all patients with COVID-19 and proximal femoral fractures? An analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in Northern Italy
title Should we operate on all patients with COVID-19 and proximal femoral fractures? An analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in Northern Italy
title_full Should we operate on all patients with COVID-19 and proximal femoral fractures? An analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in Northern Italy
title_fullStr Should we operate on all patients with COVID-19 and proximal femoral fractures? An analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in Northern Italy
title_full_unstemmed Should we operate on all patients with COVID-19 and proximal femoral fractures? An analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in Northern Italy
title_short Should we operate on all patients with COVID-19 and proximal femoral fractures? An analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in Northern Italy
title_sort should we operate on all patients with covid-19 and proximal femoral fractures? an analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in northern italy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366488/
https://www.ncbi.nlm.nih.gov/pubmed/34401931
http://dx.doi.org/10.1007/s00264-021-05166-3
work_keys_str_mv AT fusinifederico shouldweoperateonallpatientswithcovid19andproximalfemoralfracturesananalysisofthirtysixtyandninetydaymortalityratesbasedonpatientsclinicalpresentationandcomorbidityamulticentricstudyinnorthernitaly
AT massealessandro shouldweoperateonallpatientswithcovid19andproximalfemoralfracturesananalysisofthirtysixtyandninetydaymortalityratesbasedonpatientsclinicalpresentationandcomorbidityamulticentricstudyinnorthernitaly
AT risitanosalvatore shouldweoperateonallpatientswithcovid19andproximalfemoralfracturesananalysisofthirtysixtyandninetydaymortalityratesbasedonpatientsclinicalpresentationandcomorbidityamulticentricstudyinnorthernitaly
AT ferreraandrea shouldweoperateonallpatientswithcovid19andproximalfemoralfracturesananalysisofthirtysixtyandninetydaymortalityratesbasedonpatientsclinicalpresentationandcomorbidityamulticentricstudyinnorthernitaly
AT enriettiemilio shouldweoperateonallpatientswithcovid19andproximalfemoralfracturesananalysisofthirtysixtyandninetydaymortalityratesbasedonpatientsclinicalpresentationandcomorbidityamulticentricstudyinnorthernitaly
AT zoccolakristijan shouldweoperateonallpatientswithcovid19andproximalfemoralfracturesananalysisofthirtysixtyandninetydaymortalityratesbasedonpatientsclinicalpresentationandcomorbidityamulticentricstudyinnorthernitaly
AT biancogiuseppe shouldweoperateonallpatientswithcovid19andproximalfemoralfracturesananalysisofthirtysixtyandninetydaymortalityratesbasedonpatientsclinicalpresentationandcomorbidityamulticentricstudyinnorthernitaly
AT zanchinifabio shouldweoperateonallpatientswithcovid19andproximalfemoralfracturesananalysisofthirtysixtyandninetydaymortalityratesbasedonpatientsclinicalpresentationandcomorbidityamulticentricstudyinnorthernitaly
AT cologabriele shouldweoperateonallpatientswithcovid19andproximalfemoralfracturesananalysisofthirtysixtyandninetydaymortalityratesbasedonpatientsclinicalpresentationandcomorbidityamulticentricstudyinnorthernitaly